New York, NY, United States of America

Michael David Bengt Fenster

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael David Bengt Fenster. Retrieved from https://idiyas.com/inventor/michael-david-bengt-fenster

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 25.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael David Bengt Fenster: Innovator in Pharmaceutical Chemistry

Introduction

Michael David Bengt Fenster is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes in drug preparation. His work is recognized for its potential impact on the development of new therapeutic agents.

Latest Patents

Michael holds a patent for a process titled "Process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7--butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrroldin-1-yl)cyclohexyl)acetamide." This invention relates to an improved method for synthesizing a specific compound that may have therapeutic applications. He has 1 patent to his name, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Michael is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development, where he applies his expertise to advance drug discovery and formulation processes. His contributions are vital to the company's mission of delivering innovative medicines to patients.

Collaborations

Michael has collaborated with talented coworkers, including Burcu Selin Aytar and Alina Borovika. These partnerships enhance the research environment and foster innovation within the team.

Conclusion

Michael David Bengt Fenster is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new therapeutic solutions. His patent and contributions at Bristol-Myers Squibb Company reflect his commitment to advancing healthcare through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…